• Skip to main content
  • Skip to primary sidebar

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

Portfolio

/ December 20, 2021

Seqens

Seqens

SEQENS is one of the world’s leading pharmaceutical solutions and specialty ingredients companies. Headquartered in Lyon, France, SEQENS has revenues of €1.1 billion, 24 industrial sites, 10 R&D centers and 3,200 employees located across 3 continents. The Company has a product portfolio of more than 200 active pharmaceutical ingredients, 500 pharmaceutical intermediates, as well as key specialty ingredients and chemicals.

Concurrent with the acquisition, SEQENS entered a combination with Wavelength Pharmaceuticals, a former SK Capital portfolio company which is also a global manufacturer and developer of active pharmaceutical ingredients.

 

Primary Sidebar

Related News

  • SK CAPITAL PARTNERS ACQUIRES MAJORITY SHAREHOLDING OF SEQENS, A LEADER IN PHARMACEUTICALS AND SPECIALTY INGREDIENTS

    December 17, 2021

SK Capital Portfolio Companies

  • Luxium Solutions
  • VanDeMark Chemical, Inc
  • Valtris Specialty Chemicals
  • Florachem
  • Heubach
  • Seqens
  • Deltech LLC
  • Canlak
  • IPACKCHEM
  • Woodstock Sterile Solutions
  • Lacerta Group
  • Venator
  • Tilley Distribution
  • NuCera Solutions
  • Techmer PM
  • GEON
  • SI Group
  • Perimeter Solutions
  • Wavelength
  • Foremark
  • Tri-Tex
  • Niacet
  • Noramco
  • Extractas Bioscience
  • Purisys
  • Archroma
  • Addivant
  • TPC Group
  • Ascend
  • IBA Molecular
  • Calabrian Corporation
  • Halo Pharmaceutical
  • AEB Group

To request for a copy of our ESG report, please click here.

© 2023 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login